Market News & Trends
Dishman Pharmaceuticals & Chemicals Acquires Creapharm Parenterals
Switzerland-based Carbogen Amcis AG, a leading pharmaceutical process development and API manufacturing company, recently announced the acquisition of Creapharm Parenterals, a subsidiary of France-based Creapharm…
Patheon Adds Soft Gel Capsule Capabilities Through New Partnership
Patheon and PROCAPS S.A. recently announced an agreement to provide the pharmaceutical industry a new world-class line of prescription pharmaceutical soft-gel product development and manufacturing…
RaNA Therapeutics Emerges With $20.7 Million Start-Up Financing
RaNA Therapeutics, Inc. recently announced it has completed a $20.7 million round of financing co-led by Atlas Venture, SR One, and Monsanto, with participation of…
NantWorks to Invest $85.5 Million, Creating New Jobs & Drugs
California-based NantWorks, LLC, recently announced plans to locate a new pharmaceutical manufacturing plant in Terre Haute, Indiana, creating up to 234 new jobs by 2016.…
Sigma-Aldrich to Acquire BioReliance Corporation for $350 Million
BioReliance, a leading provider of global biopharmaceutical testing services, recently announced it has agreed to be acquired by Sigma-Aldrich Corporation. Avista Capital Partners, the majority…
Ventana Medical Systems & Cell Signaling Technology to Collaborate With Pfizer on Companion Diagnostic
Ventana Medical Systems, Inc., a member of the Roche Group, recently announced it has entered into a collaboration agreement with Pfizer Inc. and license agreement…
Xenon Pharmaceuticals Signs $646 Million Pain Pact With Roche
Xenon Pharmaceuticals, Inc. recently announced a strategic alliance with Genentech, a member of the Roche Group, to discover and develop compounds and companion diagnostics for…
1/17/2012
NantWorks to Invest $85.5 Million, Creating New Jobs & Drugs California-based NantWorks, LLC, recently announced plans to locate a new pharmaceutical manufacturing plant in Terre…
Brabender Pharma & Particle Sciences to Expand Extrusion Capabilities
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, is adding a Brabender Mini-Compounder 12-mm twin screw extruder, plus an ATR Torque Rheometer with single screw…
Inhibitex to be Acquired by Bristol-Myers Squibb for $2.5 Billion
Bristol-Myers Squibb Company and Inhibitex, Inc. recently announced the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire Inhibitex for $26 per…
1/10/2012
Particle Sciences Expands Program With Additional Proprietary Modeling Capabilities Particle Sciences recently announced it has added a third computational module to its DOSE program. The…
Isotechnika & Vifor Pharma Enter Development & Commercialization Agreement
Isotechnika Pharma Inc. recently announced it has signed a global development and commercialization license agreement with Vifor Pharma Ltd., the specialty pharma company of Switzerland-based…
Novavax Reports Significant Vaccine Development Progress
Novavax, Inc. recently announced that CPL Biologics (CPLB), its joint venture in India with Cadila Pharmaceuticals Ltd., has made significant progress with its vaccine development…
Particle Sciences Expands Program With Additional Proprietary Modeling Capabilities
Particle Sciences recently announced it has added a third computational module to its DOSE program. The DOSE program uses a combination of empirical data and…
Thermo Fisher Scientific Uses New Method to Determine Sialic Acids in Glycoproteins
Thermo Fisher Scientific recently announced a new method that uses high-performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) to determine sialic acids in glycoproteins. Application…
Veloxis Pharmaceuticals & Athena Drug Delivery Solutions Announce Partnership
Veloxis Pharmaceuticals and Athena Drug Delivery Solutions recently announced an alliance in which Athena will obtain exclusive rights in certain emerging market territories to manufacture…
Pulmatrix Presents iSPERSE Data for Inhaled Combination Therapies
Pulmatrix recently announced that its iSPERSE inhaled drug platform demonstrated multi-drug delivery capability and superiority over conventional lactose blending for an effective therapeutic dose of…
12/20/2011
Enlight Biosciences Forms Lucrative New Partnerships Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and Novo Nordisk. As partners in…
Covidien Plans Spin-off of Pharmaceuticals Business
Covidien plc, a leading global provider of healthcare products, recently announced it plans to spin off its pharmaceuticals business into a stand-alone public company. Covidien's…
DSM Signs Capsules Contract With QRxPharma
DSM Pharmaceutical Products, the custom manufacturing business of Royal DSM N.V., recently announced the signing of a manufacturing and supply agreement with QRxPharma, Inc., based…
